Related Experiment Video
Updated: Jun 4, 2026
Measuring Global Cellular Matrix Metalloproteinase and Metabolic Activity in 3D Hydrogels
Published on: January 22, 2019
Assessing matrix metalloproteinase expression and activity in hepatocellular carcinomas
Abstract:
The matrix metalloproteinases (MMPs) constitute a large family of zincand calcium-dependent endopeptidases that cleave extracellular matrix components (1). Hence, MMPs are classified according to their substrate specificities: interstitial collagenases, stromelysins, gelatinases, membrane-type matrix metalloproteinases (MT-MMPs), and elastase (Table 1). The regulation of MMP activity involves gene expression, proteolytic processing of the propeptides to active forms, and inhibition by specific tissue inhibitors of matrix metalloproteinase (TIMPs). MMPs are involved in situations that require extracellular matrix remodeling, including wound healing, development, inflammation, fibrosis angiogenesis, and tumor invasion (2-5). Several complementary methods have provided an insightful description of the expression levels of MMPs and their pathological correlates. These include immunohistochemistry and Northern, Western, and dot blots. Additionally, the activity of MMPs is evaluated by gel substrate analysis. This approach has demonstrated that an increase in the expression of MMP2 (6,7), MT1-MMP (7), TIMP1, and TIMP2 (8-10) is associated with liver fibrosis. Similarly, in hepatocellular carcinomas, a high expression of MMP2, MMP9, MT1-MMP, and matrilysin is related to tumor aggressiveness (11-14). Consistently, by gel substrate analysis, MMP2 activity is increased in primary and secondary liver cancers (13,15,16). By in situ hybridization, the sources of.
Insights
Matrix metalloproteinases (MMPs) are enzymes crucial for tissue remodeling in processes like wound healing and tumor invasion. Increased MMP2 and MT1-MMP expression correlates with liver fibrosis and cancer aggressiveness.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Matrix metalloproteinases (MMPs) are zinc- and calcium-dependent endopeptidases that degrade extracellular matrix components.
- MMPs are classified by substrate specificity, including collagenases, gelatinases, and membrane-type MMPs (MT-MMPs).
- MMP activity is regulated by gene expression, proteolytic activation, and inhibition by tissue inhibitors of metalloproteinase (TIMPs).
Purpose of the Study:
- To investigate the role of MMPs in extracellular matrix remodeling.
- To correlate MMP expression levels with pathological conditions such as liver fibrosis and cancer.
- To evaluate MMP activity using gel substrate analysis.
Main Methods:
- Immunohistochemistry, Northern, Western, and dot blots to assess MMP expression.
- Gel substrate analysis to evaluate MMP activity.
- In situ hybridization to determine the cellular sources of MMPs.
Main Results:
- Elevated expression of MMP2, MT1-MMP, TIMP1, and TIMP2 is associated with liver fibrosis.
- High expression of MMP2, MMP9, MT1-MMP, and matrilysin correlates with hepatocellular carcinoma aggressiveness.
- MMP2 activity is increased in primary and secondary liver cancers.
Conclusions:
- MMPs play a significant role in extracellular matrix remodeling during physiological and pathological processes.
- Aberrant MMP expression and activity are linked to the progression of liver fibrosis and hepatocellular carcinoma.
- Further research into MMP regulation may offer therapeutic targets for liver diseases and cancer.
